Recent efforts to identify and characterize prostate CSCs demonstrated that the primary PCa cell subpopulation possesses a CD44+, CD133+, and androgen receptor (AR)-negative profile, which is similar to normal human prostate stem cells10, 11. Here, CD44 is linked to posterior cortical atrophy.